Events

Oct
14
2021

Chief Medical Officer Summit 360º

Drug Development

Event Summary

Although the program is primarily designed for CMOs, large pharma CMOs and other R&D decision-makers also attended to exchange best practices in drug development and business management.

Event Description

We are pleased to welcome Dr Julie Krop, CMO, EVP, Clinical Development and Regulatory Affairs, AMAG Pharmaceuticals, Dr Zain Kassam, Co-Founder, EVP, Clinical Development and Translational Medicine, Finch Therapeutics and Dr Beth Garner, CMO, ObsEva as co-chairs for the 2021 CMO Summit.

This conference is dedicated to accomplishing two goals:

1) To bring together CMO and R&D executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits.

2) To create a network of CMOs and R&D Leadership from small to mid-size life science companies to share ideas, solutions and support.


Key Topic Areas for 2021:

The Impact of Innovation on Drug Development Operations
The Realities of Transitioning from Brick-and-Mortar Trial Sites to DCTs
Effective Outsourcing that Truly Supports Development Goals
Building a Long-Term and Global Regulatory Strategy
Structuring and Managing a Team Post-COVID
Creative Hiring Strategies with Remote Working and a Tight Job Market
CMO Preparation for Investor Interactions
The First 90 Days in a CMO Role

Price

In-Person Fee - USD 1495.0
Virtual Fee - USD 500.0

Links

BUY TICKETS NOW
BUY TICKETS NOW
BUY TICKETS NOW

Although the program is primarily designed for CMOs, large pharma CMOs and other R&D decision-makers also attended to exchange best practices in drug development and business management.
Venue

Aloft Boston Seaport District
401-403 D Street
Boston
US
02210

Contact

BreAnna Bugbee
bre@tcfllc.org
646-350-2580

Starts:
14-10-2021
12:00

Ends:
15-10-2021
20:00